How pharma is increasing clinical trial diversity

Pharma has turned its attention to health equity with razor-sharp focus in recent years. A new wave of strategies are beginning to flood the industry, including better approaches to recruiting diverse populations, attempts to overcome negative perceptions of research and efforts to take trials directly to patient communities.

INCLUDED IN THIS TRENDLINE

  • To drive trial diversity, one company is bringing them to the patient
  • What’s pharma doing wrong to improve trial diversity? ‘Everything’
  • IQVIA’s OG of data analytics on the latest clinical trial trends

Request Free!